Colorado Clinical and Translational Sciences Institute: UL1 Diversity KL2 Supplement
Colorado Clinical and Translational Sciences Institute: UL1 Diversity KL2 Supplement
批准号:
10288971
负责人:
RONALD J. SOKOL
金额:
$14.58万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2023-04-30
关键词:
Academic Medical CentersAddressAffectAfrican AmericanAmputationAntihypertensive AgentsAtlasesAwardBehaviorBeliefBiomedical ResearchCOVID-19COVID-19 patientCaringChildClinicalClinical SciencesCollaborationsColoradoCommunicationCommunitiesComputer softwareDataDevelopmentDiagnosisDiseaseDisease ManagementDrug PrescriptionsElderlyEnsureEnvironmentEthnic OriginFacultyFeedbackFosteringFundingFutureGoalsGrantGrant ReviewGuidelinesHealthHealth Services AccessibilityHealth systemHealthcareHealthcare SystemsHispanic AmericansHispanicsHomeHospitalsIndividualInformaticsInfrastructureInstitutesInterdisciplinary StudyInterventionInterviewK-Series Research Career ProgramsKnowledgeLearningLower ExtremityMeasuresMedicalMedical centerMentorsMethodologyMethodsMinorityNCI Scholars ProgramNot Hispanic or LatinoNursery SchoolsNursing FacultyOutcomeParentsPatient CarePatient RecruitmentsPatient-Focused OutcomesPatientsPerceptionPeripheral arterial diseasePharmaceutical PreparationsPhasePopulationPositioning AttributePreventive treatmentPrincipal InvestigatorProceduresProcessProgram DevelopmentProgram ReviewsProtocols documentationProviderPublic HealthRaceRare DiseasesRecommendationResearchResearch PersonnelResearch ProposalsResearch TrainingResourcesRiskRisk FactorsRoleSafetyScienceSelf ManagementServicesSpecial PopulationSurveysTestingTrainingTraining SupportTraining and EducationTranslational ResearchTranslationsUnderserved PopulationUnited States National Institutes of HealthUniversitiesWorkadherence rateadverse outcomecare deliverycare outcomescareercareer developmentcommunity engagementcommunity organizationsdesigndisparity eliminationeffectiveness implementation studyeffectiveness implementation trialethnic minority populationevidence baseexperienceformative assessmenthealth care availabilityhealth care deliveryhealth care disparityhealth care settingshealth differencehealth disparityhealth inequalitiesimplicit biasimprovedinnovationmedical specialtiesmedication compliancemeetingsmembermodifiable behaviornovelpandemic diseasepatient populationpeerprogramsracial and ethnicracial and ethnic disparitiesracial differenceresearch and developmentrisk perceptionsafety netsocial health determinantstherapy designtherapy developmenttranslational scientisttreatment disparity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Principal Investigator (Last, first, middle): Sokol, Ronald (Diversity Candidate: McNeal, Demetria, M)
SUMMARY
Abstract of NCATS-Funded UL1 Project
Funded by NIH in 2008, 2013 and 2018 the Colorado Clinical and Translational Sciences Institute (CCTSI) at
the University of Colorado Anschutz Medical Campus (CUAMC) has transformed and improved the biomedical;
research and training enterprise in the Colorado region and accelerated and catalyzed the translation of
discoveries into improved patient care and public health. The CCTSI, a partnership of CUAMC, CU Boulder,
Colorado State University, six hospitals and 20 community organizations, has established new infrastructure,
streamlined processes and expanded existing resources and services for investigators and stakeholders;
tripled the number of training and education programs supporting development of a translational workforce;
promoted team science and interdisciplinary research; established an extensive community engagement
program; created an academic home for clinical & translational scientists and trainees; and actively engaged in
CTSA network activities. CCTSI has five overall strategic goals:
Goal 1: Develop, educate and sustain a diverse translational science workforce to ensure the highest research
innovation, quality and safety.
Goal 2: Create a translational research environment in which team science and local and national collaboration
are facilitated, supported and valued.
Goal 3: Engage local and national communities and stakeholders in all phases of the translational research
process.
Goal 4: Create novel methodologies and resources to support and integrate research in special populations,
including children, the elderly, the underserved and those with rare diseases.
Goal 5: Further innovate and streamline our processes and enhance our informatics capacity for research
start-up, implementation and oversight to promote quality, efficiency, & safety of our research and our active
participation in the national CTSA Trial Innovation Network.
Dr. McNeal's proposal capitalizes on CCTSI's goals one and four and their accompanying resources in the
following ways. First, to support attainment of CCTSI goal 1, the CCTSI has established new programs and
offers resources designed to support the development of early stage career faculty. Existing programs and
resources create the ideal environment for Dr. McNeal, a junior and minority faculty member, to advance and
thrive as an independent scholar. To prepare for this submission, Dr. McNeal has already participated in one
CCTSI sponsored program (CCTSI Research Studio) in which a team of interdisciplinary senior scholars
reviewed this project proposal and provided feedback to further refine the research question and methodology.
Dr. McNeal has been competitively selected to participate in two research and career development programs:
The National Institutes of Health Programs to Increase Diversity Among Individuals Engaged in Health-Related
Research (PRIDE) and the CCTSI-sponsored Clinical Faculty Scholars Program. Additionally, Dr. McNeal has
completed two Atlas.ti courses to learn software management for qualitative data. To support learning
opportunities identified in the Mentoring Plan (see figure 2), Dr. McNeal will have access to both coursework
and hands on experiences over the course of the award period. Specific CCTSI training includes course work
through the Clinical Sciences Graduate Program, the KL2 career in progress monthly meetings, the Pre-K
grant review program and the Research Studio. Additional CCTSI trainings that Dr. McNeal will use include
Regulatory Knowledge and Support, Protocol Submission and Recruiting Participants (see table 3). Second, in
alignment with CCTSI goal 4, the study has an explicit focus on underserved populations. Dr. McNeal is
investigating Black and Hispanic American populations. The project will identify underlying clinician and
patient related factors that contribute to health disparities in outcomes and health inequities in care delivery
among African American and Hispanic patients with peripheral artery disease (PAD). This is an important and
novel project that is the first step in addressing health disparities and fits very well within the Parent U1 grant
and the functions of the CCTSI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colorado Clinical and Transational Sciences Institute
-
批准号:9926512
-
项目类别:
-
资助金额:$77.57万
-
财政年份:2019
-
负责人:RONALD J. SOKOL
-
依托单位:
NIH Prior Approval Process Professional
-
批准号:10158652
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-008
-
批准号:10414775
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-002
-
批准号:10414769
-
项目类别:
-
资助金额:$83.79万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Transational Sciences Institute
-
批准号:9926131
-
项目类别:
-
资助金额:$792.72万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-005
-
批准号:10414772
-
项目类别:
-
资助金额:$210.27万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-007
-
批准号:10414774
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-001
-
批准号:10414768
-
项目类别:
-
资助金额:$103.86万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Transational Sciences Institute
-
批准号:10402976
-
项目类别:
-
资助金额:$324.99万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-004
-
批准号:10414771
-
项目类别:
-
资助金额:$87.76万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Transational Sciences Institute
-
批准号:10414766
-
项目类别:
-
资助金额:$819.66万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-003
-
批准号:10414770
-
项目类别:
-
资助金额:$161.36万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Core-006
-
批准号:10414773
-
项目类别:
-
资助金额:$42.4万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
CCTSI Participation in the National COVID Cohort Collaborative (N3C)
-
批准号:10164981
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Admin-Core-001
-
批准号:10414767
-
项目类别:
-
资助金额:$64.77万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Transational Sciences Institute
-
批准号:10608776
-
项目类别:
-
资助金额:$14.58万
-
财政年份:2018
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Translational Sciences Institute
-
批准号:8917645
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2013
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Translational Sciences Institute
-
批准号:8720918
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2013
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Translational Sciences Institute
-
批准号:8788928
-
项目类别:
-
资助金额:$56.65万
-
财政年份:2013
-
负责人:RONALD J. SOKOL
-
依托单位:
Colorado Clinical and Translational Sciences Institute
-
批准号:8720915
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2013
-
负责人:RONALD J. SOKOL
-
依托单位:
海外基金